AIDS
Conditions
Interventions
AZT+3TC+LPV/r and AZT+3TC+EFV:Nil
ABC+3TC+LPV/r and AZT+3TC+ LPV/r:Nil
ABC+3TC+LPV/r:Nil
Sponsors
Beijing Ditan Hospital affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects younger than or equal to 14 years old; 2. HIV antibody positive subjects were detected by ELISA and confirmed by antibody confirmation test (Western blot); 3. For the subjects who have stopped breastfeeding for more than 6 weeks, the virological test of different blood samples was positive; 4. Subjects who have not received any antiretroviral therapy before and meet the criteria of antiretroviral therapy for HIV positive children / infants in the national Handbook of free antiretroviral drugs; 5. The subjects who voluntarily signed the informed consent can continue to receive follow-up.
Exclusion criteria
Exclusion criteria: 1. Subjects who could not receive long-term follow-up; 2. Patients with serious mental and neurological diseases; 3. Those subjects who have been using any drugs other than the research plan for a long time, including traditional Chinese medicine; 4. Subjects with acute infection or organ dysfunction of various diseases (patients with recent acute infection but stable condition for more than 14 days can be included in the trial); 5. Subjects that clinicians think are not suitable for this project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HIV-RNA;CD4 T-cell;blood routine;Blood chemistry; | — |
Countries
China
Contacts
Public ContactZhang Fujie
Beijing Ditan Hospital Affiliated to Capital Medical University
Outcome results
None listed